Eicosanoid metabolism in human platelets is modified by albumin

Adv Exp Med Biol. 1999:469:23-7. doi: 10.1007/978-1-4615-4793-8_4.
No abstract available

MeSH terms

  • 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid / blood
  • Arachidonate 12-Lipoxygenase / blood
  • Arachidonic Acid / blood
  • Arachidonic Acids / pharmacology
  • Binding, Competitive
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Eicosanoids / blood*
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Humans
  • Hydroxyeicosatetraenoic Acids / pharmacology
  • In Vitro Techniques
  • Kinetics
  • Lipoxygenase Inhibitors
  • Phospholipases A / antagonists & inhibitors
  • Platelet Activation / drug effects
  • Platelet Activation / physiology
  • Pyrrolidinones / pharmacology
  • Serum Albumin / metabolism*
  • Type C Phospholipases / antagonists & inhibitors

Substances

  • Arachidonic Acids
  • Eicosanoids
  • Enzyme Inhibitors
  • Estrenes
  • Hydroxyeicosatetraenoic Acids
  • Lipoxygenase Inhibitors
  • Pyrrolidinones
  • Serum Albumin
  • arachidonyltrifluoromethane
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • Arachidonic Acid
  • 5-hydroxy-6,8,11,14-eicosatetraenoic acid
  • 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid
  • 15-hydroxy-5,8,11,13-eicosatetraenoic acid
  • Arachidonate 12-Lipoxygenase
  • Phospholipases A
  • Type C Phospholipases